Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
JAMA Network Open|October 25, 2023
Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic TestingElaine Chen, Flavia M Facio, Kerry W Aradhya, et al.
Prostate Cancer and Prostatic Diseases|March 1, 2022
Germline alterations among Hispanic men with prostate cancerElizabeth Pan, Justin Shaya, Lisa Madlensky, et al.
JCO Precision Oncology|July 12, 2021
Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline VariantsAnya Mezina, Neil Philips, Zoe Bogus, et al.
The Journal of Urology|August 9, 2024
Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate CancerNeal Shore, Christopher Pieczonka, Sean Heron, et al.
Prostate Cancer and Prostatic Diseases|September 22, 2025
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patientsNeal D Shore, Christopher M Pieczonka, Sean Heron, et al.
BMC Medicine|August 18, 2021
Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort studyEden V Haverfield, Edward D Esplin, Sienna J Aguilar, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2018
Transethnic Evaluation Identifies Low-Frequency Loci Associated With 25-Hydroxyvitamin D ConcentrationsJaeyoung Hong, Kathryn E Hatchell, Jonathan P Bradfield, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 3, 2023
The landscape of reported VUS in multi-gene panel and genomic testing: Time for a changeHeidi L Rehm, Joseph T Alaimo, Swaroop Aradhya, et al.
Pageof 4